E-ISSN 2231-3206 | ISSN 2320-4672
 

Review Article 


Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.

Ashok Jaiswal.


Abstract
The prevalence of cardiovascular diseases is rapidly rising. In India, coronary artery disease is one of the leading causes of death. Evidence based guidelines are recommending multiple drug therapy (statins, aspirin, ACE-I and beta-blockers) for the prevention of CAD. Clinical data for the secondary prevention of CAD are endorsing significant mortality benefits with these evidence based therapy. In real life clinical practice, there is inadequacy of prescription for these evidence based poly-pharmacotherapy for the prevention of CAD. Further, chronic poly-pharmacotherapy is associated with poor adherence to the treatment. This poor adherence to the chronic preventive therapy has been found to be one of the major indicators for poor clinical outcome. Various clinical studies have established that FDC are associated with better patients’ compliance which can translate into better clinical outcome.

Key words: Coronary artery disease, Pollypill, Aspirin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ashok Jaiswal
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol. 2011; 1(1): 9-22.


Web Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. https://www.njppp.com/?mno=6590 [Access: March 15, 2024].


AMA (American Medical Association) Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol. 2011; 1(1): 9-22.



Vancouver/ICMJE Style

Ashok Jaiswal. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol. (2011), [cited March 15, 2024]; 1(1): 9-22.



Harvard Style

Ashok Jaiswal (2011) Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. Natl J Physiol Pharm Pharmacol, 1 (1), 9-22.



Turabian Style

Ashok Jaiswal. 2011. Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. National Journal of Physiology, Pharmacy and Pharmacology, 1 (1), 9-22.



Chicago Style

Ashok Jaiswal. "Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.." National Journal of Physiology, Pharmacy and Pharmacology 1 (2011), 9-22.



MLA (The Modern Language Association) Style

Ashok Jaiswal. "Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.." National Journal of Physiology, Pharmacy and Pharmacology 1.1 (2011), 9-22. Print.



APA (American Psychological Association) Style

Ashok Jaiswal (2011) Secondary prevention of coronary artery disease (CAD): Evidences, evidence based guidelines, and real life practices.. National Journal of Physiology, Pharmacy and Pharmacology, 1 (1), 9-22.